Commercialization and demand risk
Revenue depends on converting syringe products into repeat orders from healthcare buyers and distributors.
- Scope
- Disposable and prefillable syringe sales
- Materiality
- high
SkyAI, Inc.
SkyAI, Inc. is a U.S.-based medical device company focused on syringe products and related drug-delivery systems. Its business includes the marketing and distribution of disposable and prefillable syringes, with operations tied to both domestic and international healthcare markets.
−132 080,6 %
−202,5 %
−138 400,0 %
4.02
3.88
| % | |
|---|---|
| Disposable syringes | 45% Single-use syringe products marketed for clinical and healthcare use. |
| Prefillable syringes | 20% Syringe platforms designed for drug-delivery and pharmaceutical applications. |
| Securgard and Sologard products | 20% Named syringe product lines used in the company's commercial offering. |
| Distribution and inventory sales | 15% Sales of existing inventory and third-party medical products through distribution channels. |
The company sells to healthcare companies, distributors, hospitals, clinics, healthcare providers, and medical supply...
- Healthcare distributorsprimary
Buy syringe inventory and product lines for onward distribution into healthcare channels.
- Hospitals and clinicsprimary
Purchase syringes for direct clinical use and routine patient care.
- Healthcare companiesprimary
Source syringe products and drug-delivery systems for commercial supply arrangements.
- Government buyerssecondary
Procure syringe products for public health, medical stockpiles, or institutional use.
- Medical supply organizationssecondary
Buy and distribute syringe products to healthcare providers and institutions.
The company is headquartered in the United States and maintains a corporate office in Melville, New York...
- •United States is the corporate base and a core sales market
- •Melville, New York is the company office location
- •Hungary is an important manufacturing and testing location
- •Products are marketed in domestic and international markets
- •European customers are relevant to distribution and order fulfillment
- •Regulatory compliance differs across U.S. and foreign markets
The company is focused on commercializing and distributing syringe products while building supply relationships with...
01
Commercialize syringe productsshort-term
Revenue depends on converting product development and inventory into repeat customer orders.
02
Preserve and expand manufacturing capacityshort-term
Commercial supply requires reliable production and delivery capability.
03
Broaden distribution platformmedium-term
Representing third-party products can extend the customer base and reduce reliance on a narrow product set.
04
Build treasury and capital flexibilitymedium-term
The SOL treasury is intended to provide an additional reserve and potential funding source.
The business depends on successful commercialization of syringe products, customer acceptance, and uninterrupted...
Regulatory and quality compliance risk
Medical devices must meet FDA and comparable international standards, and failures can block sales or trigger remediation.
- Scope
- U.S. and foreign medical device distribution
- Materiality
- high
Digital asset market risk
SOL holdings and staking revenue expose the company to price volatility, custody, and transaction risk.
- Scope
- Treasury reserve and staking activities
- Materiality
- high
Inventory reserve and obsolescence risk
The company carries syringe inventory, and slow sales can require write-downs or reserves.
- Scope
- Existing syringe inventory
- Materiality
- high
Manufacturing concentration risk
A key facility in Hungary supports production and testing, so disruptions could affect supply.
- Scope
- Hungarian operations
- Materiality
- medium
Advisor and related-party governance risk
Non-arm's-length arrangements can produce less favorable commercial terms.
- Scope
- Consultant and strategic advisor relationships
- Materiality
- medium
Revenue recognition for syringe sales
Reported sales may be uneven as orders ramp
Inventory valuation and reserves
Gross margin and asset values can be reduced
Impairment of long-lived assets
Non-cash charges can materially affect earnings
Fair value of warrants and derivatives
Large gains or losses may not reflect core operations
Digital asset accounting
Balance sheet and income statement volatility
: 16/06/2026